Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy

NCT: NCT03750058 · COMPLETED

NCT IDNCT03750058
StatusCOMPLETED
Start Date2018-08-08
Completion2018-12-13

Brief Summary

Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing

Frequently Asked Questions

What is Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy?

Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy is a clinical trial registered under NCT03750058. Current status: COMPLETED.

What is the status of NCT03750058?

The current status of NCT03750058 (Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy) is: COMPLETED.

When did Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy start?

Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy started on 2018-08-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑